145 related articles for article (PubMed ID: 14505663)
1. Synthesis and evaluation of isatins and thiosemicarbazone derivatives against cruzain, falcipain-2 and rhodesain.
Chiyanzu I; Hansell E; Gut J; Rosenthal PJ; McKerrow JH; Chibale K
Bioorg Med Chem Lett; 2003 Oct; 13(20):3527-30. PubMed ID: 14505663
[TBL] [Abstract][Full Text] [Related]
2. Discovery of potent thiosemicarbazone inhibitors of rhodesain and cruzain.
Fujii N; Mallari JP; Hansell EJ; Mackey Z; Doyle P; Zhou YM; Gut J; Rosenthal PJ; McKerrow JH; Guy RK
Bioorg Med Chem Lett; 2005 Jan; 15(1):121-3. PubMed ID: 15582423
[TBL] [Abstract][Full Text] [Related]
3. Fluorinated isatin derivatives. Part 1: synthesis of new N-substituted (S)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatins as potent caspase-3 and -7 inhibitors.
Podichetty AK; Faust A; Kopka K; Wagner S; Schober O; Schäfers M; Haufe G
Bioorg Med Chem; 2009 Apr; 17(7):2680-8. PubMed ID: 19299147
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of isatin thiosemicarbazones derivatives: in vitro anti-cancer, DNA binding and cleavage activities.
Ali AQ; Teoh SG; Salhin A; Eltayeb NE; Khadeer Ahamed MB; Abdul Majid AM
Spectrochim Acta A Mol Biomol Spectrosc; 2014 May; 125():440-8. PubMed ID: 24607427
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and screening of biologically significant 5-hydroxy isatin derivatives for antioxidant activity.
Swathi K; Sarangapani M
Adv Exp Med Biol; 2015; 822():129-37. PubMed ID: 25416982
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antiepileptic activity of schiff's bases of dialkylamino alkoxy isatin derivatives.
Swathi K; Sarangapani M
Adv Exp Med Biol; 2015; 822():119-28. PubMed ID: 25416981
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of some new N(4)-substituted isatin-3-thiosemicarbazones.
Pervez H; Chohan ZH; Ramzan M; Nasim FU; Khan KM
J Enzyme Inhib Med Chem; 2009 Apr; 24(2):437-46. PubMed ID: 18629680
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and anti-plasmodial evaluation in vitro of new 4-aminoquinoline isatin derivatives.
Chiyanzu I; Clarkson C; Smith PJ; Lehman J; Gut J; Rosenthal PJ; Chibale K
Bioorg Med Chem; 2005 May; 13(9):3249-61. PubMed ID: 15809160
[TBL] [Abstract][Full Text] [Related]
10. Syntheses of some substituted isatin-beta-thiosemicarbazones and isatin-beta-hydrazonothiazoline derivatives as potential antiviral and antimicrobial agents.
Omar AM; Eshba NH; Salama HM
Arch Pharm (Weinheim); 1984 Aug; 317(8):701-9. PubMed ID: 6497599
[No Abstract] [Full Text] [Related]
11. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
[TBL] [Abstract][Full Text] [Related]
12. Combinatorial optimization of isatin-beta-thiosemicarbazones as anti-poxvirus agents.
Pirrung MC; Pansare SV; Sarma KD; Keith KA; Kern ER
J Med Chem; 2005 Apr; 48(8):3045-50. PubMed ID: 15828843
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticonvulsant activity of some new thiosemicarbazone and 4-thiazolidone derivatives bearing an isatin moiety.
Karali N; Gürsoy A
Farmaco; 1994 Dec; 49(12):819-22. PubMed ID: 7893339
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of anti-HIV activity of isatin beta-thiosemicarbazone derivatives.
Bal TR; Anand B; Yogeeswari P; Sriram D
Bioorg Med Chem Lett; 2005 Oct; 15(20):4451-5. PubMed ID: 16115762
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of a sugar-based thiosemicarbazone series and structure-activity relationship versus the parasite cysteine proteases rhodesain, cruzain, and Schistosoma mansoni cathepsin B1.
Fonseca NC; da Cruz LF; da Silva Villela F; do Nascimento Pereira GA; de Siqueira-Neto JL; Kellar D; Suzuki BM; Ray D; de Souza TB; Alves RJ; Sales Júnior PA; Romanha AJ; Murta SM; McKerrow JH; Caffrey CR; de Oliveira RB; Ferreira RS
Antimicrob Agents Chemother; 2015 May; 59(5):2666-77. PubMed ID: 25712353
[TBL] [Abstract][Full Text] [Related]
16. The structure-activity relationships of the antiviral chemotherapeutic activity of isatin beta-thiosemicarbazone.
BAUER DJ; SADLER PW
Br J Pharmacol Chemother; 1960 Mar; 15(1):101-10. PubMed ID: 13797622
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
[TBL] [Abstract][Full Text] [Related]
18. Studies on potential antiviral compounds, XXIV. New 1-substituted isatin beta-thiosemicarbazones.
Ferranti A; Garuti L; Giovanninetti G; Katz E
Arch Pharm (Weinheim); 1985 May; 318(5):415-21. PubMed ID: 4026537
[No Abstract] [Full Text] [Related]
19. Potential biologically active agents, XXXII. Synthesis and antiviral activity of some 3-(arylthiosemicarbazono)-2-indolinones.
Varma RS; Garg PK; Verma HN; Awasthi LP
Arch Pharm (Weinheim); 1981 Nov; 314(11):918-22. PubMed ID: 7325787
[No Abstract] [Full Text] [Related]
20. Synthesis and biological evaluation of some new N4-aryl substituted 5-chloroisatin-3-thiosemicarbazones.
Pervez H; Ramzan M; Yaqub M; Nasim FU; Khan KM
Med Chem; 2012 May; 8(3):505-14. PubMed ID: 22530899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
